KAMES CAPITAL plc Has $6.96 Million Stake in Atrion Co. (ATRI)

KAMES CAPITAL plc trimmed its position in Atrion Co. (NASDAQ:ATRI) by 17.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,924 shares of the medical instruments supplier’s stock after selling 1,623 shares during the quarter. KAMES CAPITAL plc owned approximately 0.43% of Atrion worth $6,963,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. TIAA CREF Investment Management LLC raised its position in shares of Atrion by 9.1% during the third quarter. TIAA CREF Investment Management LLC now owns 9,276 shares of the medical instruments supplier’s stock worth $6,445,000 after acquiring an additional 776 shares during the last quarter. Virginia Retirement Systems ET AL acquired a new stake in Atrion in the fourth quarter valued at approximately $889,000. Raymond James Financial Services Advisors Inc. boosted its position in shares of Atrion by 14.8% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 4,125 shares of the medical instruments supplier’s stock valued at $3,057,000 after buying an additional 531 shares during the last quarter. Waldron Private Wealth LLC purchased a new position in shares of Atrion during the third quarter valued at approximately $240,000. Finally, Vanguard Group Inc boosted its position in shares of Atrion by 1.1% during the third quarter. Vanguard Group Inc now owns 84,115 shares of the medical instruments supplier’s stock valued at $58,443,000 after buying an additional 932 shares during the last quarter. Institutional investors own 61.74% of the company’s stock.

Several brokerages have issued reports on ATRI. BidaskClub upgraded Atrion from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, March 27th. ValuEngine upgraded Atrion from a “hold” rating to a “buy” rating in a report on Monday, February 4th.

ATRI stock traded down $15.94 on Wednesday, reaching $866.01. 26 shares of the company traded hands, compared to its average volume of 6,308. The firm has a market cap of $1.61 billion, a PE ratio of 48.88 and a beta of 0.44. Atrion Co. has a one year low of $560.65 and a one year high of $948.03.

The company also recently announced a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 15th were issued a $1.35 dividend. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $5.40 annualized dividend and a dividend yield of 0.62%.

TRADEMARK VIOLATION WARNING: “KAMES CAPITAL plc Has $6.96 Million Stake in Atrion Co. (ATRI)” was reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this article on another domain, it was illegally copied and republished in violation of international copyright legislation. The correct version of this article can be accessed at https://www.baseballdailydigest.com/news/2019/04/17/atrion-co-atri-stake-lessened-by-kames-capital-plc.html.

Atrion Company Profile

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Further Reading: Preferred Stock

Institutional Ownership by Quarter for Atrion (NASDAQ:ATRI)

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.